ID: ALA1160826

Max Phase: Preclinical

Molecular Formula: C8H17NO5

Molecular Weight: 207.23

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  NCC[C@@H]1OC(CO)C(O)C(O)C1O

Standard InChI:  InChI=1S/C8H17NO5/c9-2-1-4-6(11)8(13)7(12)5(3-10)14-4/h4-8,10-13H,1-3,9H2/t4-,5?,6?,7?,8?/m0/s1

Standard InChI Key:  BNFUZESWWRCHFC-DKBGPPMCSA-N

Associated Targets(Human)

Brain glycogen phosphorylase 474 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 207.23Molecular Weight (Monoisotopic): 207.1107AlogP: -2.82#Rotatable Bonds: 3
Polar Surface Area: 116.17Molecular Species: BASEHBA: 6HBD: 5
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.61CX Basic pKa: 9.83CX LogP: -3.25CX LogD: -5.58
Aromatic Rings: 0Heavy Atoms: 14QED Weighted: 0.34Np Likeness Score: 2.01

References

1. Pan D, Liu J, Senese C, Hopfinger AJ, Tseng Y..  (2004)  Characterization of a ligand-receptor binding event using receptor-dependent four-dimensional quantitative structure-activity relationship analysis.,  47  (12): [PMID:15163189] [10.1021/jm030586a]

Source